Abstract
Radical prostatectomy has in randomised settings failed to demonstrate a survival difference in patients with low-risk prostate cancer when tested against an observational strategy. Active surveillance has been introduced in order to reduce overtreatment by distinguishing between cancers with a biological potential, and truly indolent cancers best left untreated. Preliminary results from large prospective active surveillance cohorts are promising; however, uncertainties persist concerning optimal patient selection and follow-up, as well as the long-term safety.
| Bidragets oversatte titel | Active surveillance is a useful strategy in the management of patients with low-risk prostate cancer |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 177 |
| Udgave nummer | 18 |
| Sider (fra-til) | 841-5 |
| Antal sider | 5 |
| ISSN | 0041-5782 |
| Status | Udgivet - 2015 |
Emneord
- Disease Progression
- Humans
- Male
- Neoplasm Grading
- Prostate-Specific Antigen/blood
- Prostatic Neoplasms/diagnosis
- Risk Assessment
- Unnecessary Procedures
- Watchful Waiting